26 results
S-8 POS
EX-4.5
PYXS
Pyxis Oncology Inc
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
to mean “and/or”; (c) words denoting any gender shall include all genders; (d) the word “hereunder” refers to under this Plan as a whole and not merely
S-8
EX-4.5
PYXS
Pyxis Oncology Inc
23 Aug 23
Registration of securities for employees
5:28pm
to mean “and/or”; (c) words denoting any gender shall include all genders; (d) the word “hereunder” refers to under this Plan as a whole and not merely
425
APGN
Apexigen Inc
24 May 23
Business combination disclosure
7:05am
to each term defined herein shall be equally applicable to both the singular and the plural forms of such term, and words denoting any gender shall
425
kt9ducwmmaq3ohim6a5
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
68fdz9 rk9njd5rmxp
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
S-3
EX-1.2
i9nve uu2cz
1 Nov 22
Shelf registration
4:51pm
DEF 14A
k93r3yas1c37s33
28 Apr 22
Definitive proxy
4:33pm
10-K
q9zvlyo802sjt37ugpj
29 Mar 22
Annual report
7:36am
424B4
etagczu
8 Oct 21
Prospectus supplement with pricing info
5:00pm
S-1
EX-10.12
06xa1hqvb3ht26ns m7
17 Sep 21
IPO registration
5:00pm
S-1
f2vltqexzh8m6rg
17 Sep 21
IPO registration
5:00pm
S-1
EX-10.7
31qi23 0v
17 Sep 21
IPO registration
5:00pm
S-1
EX-10.10
h6bhk i4uwq4adcmb2ey
17 Sep 21
IPO registration
5:00pm